EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Prediction of Extraintestinal Manifestations in Inflammatory Bowel Disease Using Clinical and Genetic Variables with Machine Learning in a Latin IBD Group

Tamara Pérez-Jeldres, Paula Reyes-Pérez, Patricio Gonzalez-Hormazabal, Cristóbal Avendano, Roberto Segovia Melero, Lorena Azocar, Veronica Silva, Andres De La Vega, Elizabeth Arriagada, Elisa Hernandez, Nataly Aguilar, Carolina Pavez-Ovalle und 7 weitere

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26125741 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Tamara Pérez-Jeldres und 18 weiteren Autor:innen. Beteiligte Einrichtung: Departmento de Gastroenterología, Pontificia University Católica de Chile, Santiago 8330024, Chile. Hauptthemen laut MEDLINE: Machine Learning, Inflammatory Bowel Diseases, Crohn Disease, Colitis, Ulcerative. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Agencia Nacional de Investigación y Desarrollo, ANID, Chile, Project Fondecyt Initiation, ANID, Chile, Project Fondecyt Regular.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Extraintestinal manifestations (EIMs) significantly increase morbidity in inflammatory bowel disease (IBD) patients. In this study, we examined clinical and genetic factors associated with EIMs in 414 Latin IBD patients, utilizing machine learning for predictive modeling. In our IBD group (314 ulcerative colitis (UC) and 100 Crohn’s disease (CD) patients), EIM presence was assessed. Clinical differences between patients with and without EIMs were analyzed using Chi-square and Mann–Whitney U tests. Based on the genetic data of 232 patients, we identified variants linked to EIMs, and the polygenic risk score (PRS) was calculated. A machine learning approach based on logistic regression (LR), random forest (RF), and gradient boosting (GB) models was employed for predicting EIMs. EIMs were present in 29% (120/414) of patients. EIM patients were older (52 vs. 45 years, p = 0.01) and were more likely to have a family history of IBD (p = 0.02) or use anti-TNF therapy (p = 0.01). EIMs were more common in patients with CD than in those with UC without reaching statistical significance (p = 0.06). Four genetic variants were associated with EIM risk (rs9936833, rs4410871, rs3132680, and rs3823417). While the PRS showed limited predictive power (AUC = 0.69), the LR, GB, and RF models demonstrated good predictive capabilities. Approximately one-third of IBD patients experienced EIMs. Significant risk factors included genetic variants, family history, age, and anti-TNF therapy, with predictive models effectively identifying EIM risk.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Machine LearningInflammatory Bowel DiseasesCrohn DiseaseColitis, UlcerativeHumansFemaleMaleMiddle AgedAdultGenetic Predisposition to DiseasePolymorphism, Single NucleotideRisk Factors

Stichwörter der Autor:innen

extraintestinal manifestationgenetic variantsinflammatory bowel disease

Autor:innen und Institutionen

  • Departmento de Gastroenterología, Pontificia University Católica de Chile, Santiago 8330024, Chile.
  • Departmento de Gastroenterología, Hospital san Borja Arriaran, Santiago 8360160, Chile.
  • Laboratorio Internacional de Investigación Sobre el Genoma Humano, University Nacional Autónoma de Mexico, Mexico 76230, Mexico.
  • Programa de Genética Humana, Facultad de Medicina, Instituto de Ciencias Biomédicas (ICBM), Santiago 8380453, Chile.
  • Departmento de Ciencias de la Computación, Pontificia University Católica de Chile, Santiago 7820436, Chile.
  • Departmento de Enfermedades Respiratorias, Escuela de Medicina, Pontificia University Católica de Chile, Santiago 8330024, Chile.

ORCID-Profile: Roberto Candia, Ivania Valdes, Maria Leonor Bustamante

Förderung

  • Agencia Nacional de Investigación y Desarrollo
  • ANID, Chile, Project Fondecyt Initiation
  • ANID, Chile, Project Fondecyt Regular

Zitieren

APA

Pérez-Jeldres, T., Reyes-Pérez, P., Gonzalez-Hormazabal, P., Avendano, C., Segovia Melero, R., Azocar, L., Silva, V., De La Vega, A., Arriagada, E., Hernandez, E., Aguilar, N., Pavez-Ovalle, C., Hernández-Rocha, C., Candia, R., Miquel, J. F., Alvarez-Lobos, M., Valdes, I., Medina-Rivera, A., & Bustamante, M. L. (2025). Prediction of Extraintestinal Manifestations in Inflammatory Bowel Disease Using Clinical and Genetic Variables with Machine Learning in a Latin IBD Group. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26125741

Vancouver

Pérez-Jeldres T, Reyes-Pérez P, Gonzalez-Hormazabal P, Avendano C, Segovia Melero R, Azocar L, et al. Prediction of Extraintestinal Manifestations in Inflammatory Bowel Disease Using Clinical and Genetic Variables with Machine Learning in a Latin IBD Group. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26125741

BibTeX
@article{PrezJeldres2025,
  author = {Pérez-Jeldres, Tamara and Reyes-Pérez, Paula and Gonzalez-Hormazabal, Patricio and Avendano, Cristóbal and Segovia Melero, Roberto and Azocar, Lorena and Silva, Veronica and De La Vega, Andres and Arriagada, Elizabeth and Hernandez, Elisa and Aguilar, Nataly and Pavez-Ovalle, Carolina and Hernández-Rocha, Cristian and Candia, Roberto and Miquel, Juan Francisco and Alvarez-Lobos, Manuel and Valdes, Ivania and Medina-Rivera, Alejandra and Bustamante, Maria Leonor},
  title = {Prediction of Extraintestinal Manifestations in Inflammatory Bowel Disease Using Clinical and Genetic Variables with Machine Learning in a Latin IBD Group},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26125741}
}
Kostenlos starten →